Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001628280-26-033831
Filing Date
2026-05-12
Accepted
2026-05-12 06:07:27
Documents
2
Period of Report
2026-05-12

Document Format Files

Seq Description Document Type Size
1 6-K a6k-iphx260512.htm 6-K 8463
2 EX-99.1 exhibit991-260512.htm EX-99.1 14598
  Complete submission text file 0001628280-26-033831.txt   24446
Mailing Address 117 AVENUE DE LUMINY BP 30191 MARSEILLE FRANCE France 13009
Business Address 117 AVENUE DE LUMINY BP 30191 MARSEILLE FRANCE France 13009 33430303030
Innate Pharma SA (Filer) CIK: 0001598599 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
LEI: 9695002Y8420ZB8HJE29
Type: 6-K | Act: 34 | File No.: 001-39084 | Film No.: 26965700
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)